The 65-year-old eye care brand is applying AI technologies and rolling out new prototype store designs to enhance the customer and patient experience.• Owned by Paris-based EssilorLuxottica, Pearl Vis ...

Dr. Andrews will lead clinical strategy, align optometric care, and ensure high-quality, accessible eye care programs.

Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies to improve vision in dry AMD. Many patients continue to live with central ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Entschuldigung, es scheint, dass die Beschreibung, die Sie bereitgestellt haben, bereits auf Deutsch (de) ist. Wenn Sie möchten, dass ich es in eine andere Sprache übersetze oder bei etwas anderem ...

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...

CLIFTON FORGE, Va. (WDBJ) - Leah Haymaker was diagnosed with Stargardt disease, a common, inherited juvenile macular degeneration causing progressive, untreatable central vision loss, at age four. For ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

Researchers analyzing U.S. safety reports say certain medications containing semaglutide may be linked to a rare eye ...